dc.contributor.author | Nieves, Christina I. | |
dc.contributor.author | Kaida, Angela | |
dc.contributor.author | III, George R. Seage | |
dc.contributor.author | Kabakyenga, Jerome | |
dc.contributor.author | Muyindike, Winnie | |
dc.contributor.author | Boum, Yap | |
dc.contributor.author | Mocello, A. Rain | |
dc.contributor.author | Martin, Jeffrey N. | |
dc.contributor.author | Hunte, Peter W. | |
dc.contributor.author | Haberer, Jessica E. | |
dc.contributor.author | Bangsberg, David R. | |
dc.contributor.author | Matthews, Lynn T. | |
dc.date.accessioned | 2022-01-28T09:04:51Z | |
dc.date.available | 2022-01-28T09:04:51Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | Nieves, C. I., Kaida, A., Seage III, G. R., Kabakyenga, J., Muyindike, W., Boum, Y., ... & Matthews, L. T. (2015). The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda. Contraception, 92(2), 152-159. | en_US |
dc.identifier.uri | http://ir.must.ac.ug/xmlui/handle/123456789/1296 | |
dc.description.abstract | Objective: The objective was to determine individual and dyadic factors associated with effective contraceptive use among human immunodeficiency virus (HIV)-infected women accessing antiretroviral therapy (ART) in rural Uganda.
Study design: HIV-infected women enrolled in the Uganda AIDS Rural Treatment Outcomes cohort completed questionnaires (detailing socio-behavioral characteristics, sexual and reproductive history, contraceptive use, fertility desires) and phlebotomy (October 2011–March
2013). We describe prevalence of effective contraceptive use (i.e., consistent condom use and/or oral contraceptives, injectable hormonal contraception, intrauterine device, female sterilization) in the previous 6 months among sexually active, non-pregnant women (18–40 years). We assessed covariates of contraceptive use using multivariable logistic regression.
Results: A total of 362 women (median values: age 30 years, CD4 count 397 cells/mm3, 4.0 years since ART initiation) were included. Among 284 sexually active women, 50% did not desire (another) child, and 51% had a Sero-concordant partner. Forty-five percent (n=127) reported effective contraceptive use, of whom 57% (n=72) used condoms, 42% (n=53) injectable, 12% (n=15) oral contraceptives and 11% (n=14) other effective methods. Dual contraception was reported by 6% (n=8). Only “partnership fertility desire” was independently associated with contraceptive use; women who reported that neither partner desired a child had significantly increased odds of contraceptive use (adjusted odds ratio: 2.40, 95% confidence interval: 1.07–5.35) compared with women in partnerships where at least one partner desired a child.
Conclusions: Less than half of sexually active HIV-infected women accessing ART used effective contraception, of which 44% (n=56) relied exclusively on male condoms, highlighting a continued need to expand access to a wider range of longer-acting female controlled contraceptive methods. Association with partnership fertility desire underscores the need to include men in reproductive health programming | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | Contraception | en_US |
dc.subject | HIV | en_US |
dc.subject | Antiretroviral therapy | en_US |
dc.subject | Family planning | en_US |
dc.subject | Contraceptive use | en_US |
dc.subject | Uganda | en_US |
dc.title | The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda | en_US |
dc.type | Article | en_US |